Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-002186
Filing Date
2022-02-25
Accepted
2022-02-25 17:03:25
Documents
9
Effectiveness Date
2022-02-25

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220224xs8.htm S-8 144401
2 EX-5.1 tmb-20220224xex5d1.htm EX-5.1 10179
3 EX-23.1 tmb-20220224xex23d1.htm EX-23.1 2835
4 EX-FILING FEES tmb-20220224xexfilingfees.htm EX-FILING FEES 32159
5 GRAPHIC tmb-20220224xs8001.jpg GRAPHIC 691
6 GRAPHIC tmb-20220224xs8005.jpg GRAPHIC 879
7 GRAPHIC tmb-20220224xex5d1002.jpg GRAPHIC 11135
8 GRAPHIC tmb-20220224xex5d1003.jpg GRAPHIC 25574
9 GRAPHIC tmb-20220224xex5d1001.jpg GRAPHIC 5026
  Complete submission text file 0001558370-22-002186.txt   251025
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263052 | Film No.: 22681623
SIC: 8071 Services-Medical Laboratories